GO
Loading...

Biogen Idec Inc

More

  • US STOCKS-Wall St rises at open, S&P 500 near record Monday, 12 May 2014 | 10:18 AM ET

    *Ukraine situation remains in focus after referendum. The advance game despite ongoing geopolitical concerns in the Ukraine after pro-Russian rebels voted in favor of self-rule in eastern regions of the country in a referendum dismissed by Kiev and Western governments as illegal.

  • May 12- Biogen Idec Inc and partner Swedish Orphan Biovitrum AB on Monday said they will donate hemophilia drugs for use in developing nations in quantities large enough to treat tens of thousands of patients over the next decade.

  • Look beyond Silicon Valley for lasting innovation Tuesday, 29 Apr 2014 | 7:00 AM ET
    Houston, Texas.

    While VC firms may reward entrepreneurs in NYC and San Fran, may believe that longer-term innovations happening elsewhere are key to economic growth.

  • Biogen barreling down on Alzheimer's     Wednesday, 23 Apr 2014 | 3:33 PM ET

    CNBC's Meg Tirrell speaks with George Scangos, Biogen Idec CEO, about the drug maker's fight against MS and Alzheimer's. Scangos also comments on Valeant's bid for Alllergan.

  • *AT&T falls after results, but Boeing rallies. *Amgen drags biotech lower, but Gilead gains. NEW YORK, April 23- U.S. stocks declined on Wednesday after a six-session winning streak as gains in Boeing and Gilead were offset by slides in AT&T and the wider biotech sector.

  • Midday movers: Facebook, Gilead Sciences & More Wednesday, 23 Apr 2014 | 12:20 PM ET
    SodaStream soda

    Some of Wednesday's midday movers:

  • *AT&T falls after results, but Boeing rallies. *Amgen drags biotech lower, but Gilead gains. NEW YORK, April 23- U.S. stocks edged lower on Wednesday as weakness in AT&T and biotech names inspired investors to take profits following six straight days of gains, though a rally in Boeing limited losses.

  • US STOCKS-Wall St edges lower following six-day S&P rally Wednesday, 23 Apr 2014 | 10:17 AM ET

    *Boeing rallies after results, outlook; AT&T drops. NEW YORK, April 23- U.S. stocks edged lower on Wednesday as strong results from Boeing failed to inspire investors to keep pushing equities higher following six straight days of gains.

  • April 23- Biogen Idec Inc on Wednesday reported a higher first-quarter profit as sales of its new Tecfidera multiple sclerosis drug extended a run of eclipsing Wall Street sales expectations, and the U.S. biotechnology company raised its full-year forecasts.

  • April 23- Biogen Idec Inc on Wednesday reported a higher first-quarter profit as sales of its new Tecfidera multiple sclerosis drug extended its run of eclipsing Wall Street sales forecasts.

  • Market shift could drive further advance: Cramer Tuesday, 22 Apr 2014 | 6:04 PM ET

    Looking at the modest gains in the Dow and S&P, you wouldn’t think anything big happened in the market. But it did.

  • *Netflix climbs in extended-hours trading after results. NEW YORK, April 21- U.S. stocks advanced modestly on Monday in subdued trading as investors showed hesitation in the wake of a strong rally last week and before a slew of key earnings releases this week.

  • Ackman, Valeant pursuing takeover of Allergan Monday, 21 Apr 2014 | 4:46 PM ET
    Bill Ackman

    Activist investor William Ackman of Pershing Square Capital and Valeant Pharmaceuticals International are said to be pursuing a takeover of Allergan.

  • *Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks advanced modestly on Monday as investors showed hesitation in the wake of a strong rally last week and ahead of key earnings releases. The S&P 500 posted its best week since July last week, boosted by results from such names as General Electric Co and Morgan Stanley.

  • Can Gilead’s Sovaldi rescue biotech? Monday, 21 Apr 2014 | 12:20 PM ET
    A researcher works on a hepatitis C virus drug at Gilead Sciences lab in Foster City, Calif.

    Biotech earnings kick off Tuesday after the bell as Gilead and Amgen report. Here's what to watch for.

  • *Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks rose slightly on Monday as investors found few reasons to push indexes sharply higher following a strong rally last week and ahead of key earnings releases.

  • US STOCKS-Wall St flat as investors await earnings Monday, 21 Apr 2014 | 10:51 AM ET

    *Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks were flat on Monday ahead of key earnings releases as investors found few reasons to push indexes sharply higher following a strong rally last week. The S&P 500 posted its best week since July last week, boosted by results from such names as General Electric Co and Morgan Stanley.

  • *Results from Netflix expected after the market close. *The S&P 500 had its best week since July last week, boosted by strong results from such names as General Electric Co and Morgan Stanley. However, thus far the earnings season has been mixed, with technology names like Google Inc and IBM struggling to impress investors.

  • April 18- Biogen Idec Inc is pricing its newly approved long-acting hemophilia drug, Alprolix, to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.

  • Several behemoths, including Apple, the largest U.S. company by market value, as well as Microsoft, McDonald's and AT&T, are due to report earnings.